Font Size:
a
A
A
Keyword [TKI therapy]
Result: 1 - 10 | Page: 1 of 1
1.
Predictors Of EGFR-TKI Therapy In Chinese NSCLC And Mechanisms Of Downstream Signal Pathway In EGFR Family
2.
Predictive Role Of Pretreatment EGFR T790M Mutation On TKI Therapy In NSCLC Patients-a Meta-analysis
3.
The Pharmacodynamic Experiment And Retrospective Study Of Pemetrexed Combined With EGFR-TKI In Lung Squamous Cell Cancer
4.
The Significance Of PD-L1 Expression In A Cohort Of Patientswith EGRF Mutation-positive Lung Adenocarcinoma
5.
The Clinical Observation Of Therapeutic Regimens For Slow Progression Advanced NSCLC After First-line EGFR-TKI Therapy
6.
Detection Of Peripheral Blood Lymphocyte Subsets In Chronic Myeloid Leukemia And Its Clinical Significance
7.
The Relationship Between EGFR Gene Mutation In Tissues And Blood Form The Patients Of Lung Adenocarcinoma And Clinicopathological Features And Short-term Efficacy Of TKI Therapy
8.
Dynamic Monitoring Of Lymphocyte Subpopulation During The EGFR-TKI Therapy For Predicting The Efficacy And Resistance Of EGFR-TKI In EGFR Mutated Lung Cancer Patients
9.
Study On The Changes Of Plasma T790M Gene Mutation After TKI Therapy In Patients With Advanced Non-small Cell Lung Cancer
10.
A Radiomic Approach To Predict The EGFR-TKI Therapy Response Of Non-small Cell Lung Cancer Patients
<<First
<Prev Next>
Last>>
Jump to
